retatrutide phase 3 Today, we shared new data from the latest study of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more Phase III retatrutide study demonstrates

As many have noted the continuation of the perioperative effects GLP-1 RAs have on patients, even after seemingly adequate time since discontinuation in addition to following strict fasting guidelines, there have expectedly been new estimates on appropriate discontinuation strategies

All visits happen through telehealth, so you can get started from the comfort of your home

Known Side Effects The most common side effects across all GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhoea, and constipation

However, patients should verify individual provider qualifications, as telehealth platforms vary in the depth of subspecialty training or obesity-medicine certification among their networks

Counsel patients on habits: eat slowly, only when hungry, stop when full